EMD Millipore Collaborates with Peking University in Training of Pharmaceutical Development, Manufacturing, and Regulatory Professionals in China

EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany has been invited to serve on the faculty of the Center for Pharmaceutical Information and Engineering Research (CPIER) at Peking University in Beijing, China. The program, established in 2006 with the help of the U.S. Food and Drug Administration, relies on faculty from industry partners to prepare master’s degree candidates in its international pharmaceutical engineering program, allowing future leaders to gain a deeper understanding of pharmaceutical research and development, manufacturing, and regulatory agencies in China.

In a statement, Jean-Paul Mangeolle, head of EMD Millipore’s Process Solutions business said, “Our expertise will help ensure that education focuses on the quality and safety of products, made and consumed locally, in the years to come.”

The CPIER’s education program has a faculty of approximately 80 lectureres and 170 master’s degree students who work at manager-level positions in the biopharmaceutical industry. Faculty from EMD Millipore teach a module on quality and production processes, focusing on sterilizing filtration, aseptic processing, and critical filter validation.

EMD Millipore opened a biopharmaceutical technical and training center in Shanghai, China, in 2011.